Search by Drug Name or NDC

    NDC 65162-0778-49 Budesonide 3 mg/1 Details

    Budesonide 3 mg/1

    Budesonide is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is BUDESONIDE.

    Product Information

    NDC 65162-0778
    Product ID 65162-778_fba76108-353d-4a7d-8aa2-b05be8f476cb
    Associated GPIs 22100012006720
    GCN Sequence Number 025750
    GCN Sequence Number Description budesonide CAPDR - ER 3 MG ORAL
    HIC3 P5A
    HIC3 Description GLUCOCORTICOIDS
    GCN 28680
    HICL Sequence Number 006545
    HICL Sequence Number Description BUDESONIDE
    Brand/Generic Generic
    Proprietary Name Budesonide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Budesonide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 3
    Active Ingredient Units mg/1
    Substance Name BUDESONIDE
    Labeler Name Amneal Pharmaceuticals LLC
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206200
    Listing Certified Through 2024-12-31

    Package

    NDC 65162-0778-49 (65162077849)

    NDC Package Code 65162-778-49
    Billing NDC 65162077849
    Package 21 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-49)
    Marketing Start Date 2017-09-15
    NDC Exclude Flag N
    Pricing Information N/A